Research Perspective: Potential Role of Nitazoxanide in Ovarian Cancer Treatment. Old Drug, New Purpose?

Among gynecological malignancies epithelial ovarian cancer (EOC) is the leading cause of death. Despite improvements in conventional chemotherapy combinations, the overall cure rate has remained mostly stable over the years, and only 10%–15% of patients maintain a complete response following first-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Santo, Nicola, Ehrisman, Jessie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Concept Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795384/
https://www.ncbi.nlm.nih.gov/pubmed/24202339
http://dx.doi.org/10.3390/cancers5031163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795384/
https://www.ncbi.nlm.nih.gov/pubmed/24202339
http://dx.doi.org/10.3390/cancers5031163

Ejemplares similares